SU1056902A3 - Способ получени производных @ -гетероциклил-4-пиперидинаминов или их солей - Google Patents

Способ получени производных @ -гетероциклил-4-пиперидинаминов или их солей Download PDF

Info

Publication number
SU1056902A3
SU1056902A3 SU792747000A SU2747000A SU1056902A3 SU 1056902 A3 SU1056902 A3 SU 1056902A3 SU 792747000 A SU792747000 A SU 792747000A SU 2747000 A SU2747000 A SU 2747000A SU 1056902 A3 SU1056902 A3 SU 1056902A3
Authority
SU
USSR - Soviet Union
Prior art keywords
methyl
phenyl
dihydro
alkyl
hydrogen
Prior art date
Application number
SU792747000A
Other languages
English (en)
Russian (ru)
Inventor
Хансен Франс
Стокброкс Раймон
Торреман Жозеф
Люйкс Марсель
Original Assignee
Жансен Фармасетика Н.В. (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26670178&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SU1056902(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/002,276 external-priority patent/US4219559A/en
Application filed by Жансен Фармасетика Н.В. (Фирма) filed Critical Жансен Фармасетика Н.В. (Фирма)
Application granted granted Critical
Publication of SU1056902A3 publication Critical patent/SU1056902A3/ru
Priority to LV920187A priority Critical patent/LV5016A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
SU792747000A 1978-04-03 1979-04-03 Способ получени производных @ -гетероциклил-4-пиперидинаминов или их солей SU1056902A3 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LV920187A LV5016A3 (lv) 1978-04-03 1992-11-09 N-heterociklil-4-piperidinaminu atvasinajumu vai to salu iegusanas metode

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89253478A 1978-04-03 1978-04-03
US06/002,276 US4219559A (en) 1979-01-10 1979-01-10 N-Heterocyclyl-4-piperidinamines

Publications (1)

Publication Number Publication Date
SU1056902A3 true SU1056902A3 (ru) 1983-11-23

Family

ID=26670178

Family Applications (1)

Application Number Title Priority Date Filing Date
SU792747000A SU1056902A3 (ru) 1978-04-03 1979-04-03 Способ получени производных @ -гетероциклил-4-пиперидинаминов или их солей

Country Status (29)

Country Link
EP (1) EP0005318B1 (de)
JP (2) JPS54151982A (de)
AT (1) AT373887B (de)
AU (1) AU523352B2 (de)
BG (1) BG38164A3 (de)
CA (1) CA1140119A (de)
CS (1) CS256358B2 (de)
CY (1) CY1250A (de)
DE (1) DE2961740D1 (de)
DK (1) DK169325B1 (de)
EG (1) EG13913A (de)
ES (1) ES479206A1 (de)
FI (1) FI64801C (de)
GR (1) GR64907B (de)
HK (1) HK3184A (de)
HU (1) HU182965B (de)
IE (1) IE47818B1 (de)
IL (1) IL56992A (de)
MY (1) MY8500046A (de)
NO (2) NO154058C (de)
NZ (1) NZ189978A (de)
PH (1) PH15877A (de)
PL (1) PL123380B1 (de)
PT (1) PT69429A (de)
RO (1) RO79320A (de)
SG (1) SG29883G (de)
SU (1) SU1056902A3 (de)
YU (2) YU42484B (de)
ZA (1) ZA791557B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA19091A1 (fr) * 1980-03-10 1981-10-01 Janssen Pharmaceutica Nv Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine .
IN156065B (de) * 1982-07-12 1985-05-04 Janssen Pharmaceutica Nv
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
JPS60174778A (ja) * 1984-01-09 1985-09-09 ジヤンセン・フア−マシユ−チカ・ナ−ムロ−ゼ・フエンノ−トシヤツプ Ｎ−ヘテロシクリル−４−ピペリジンアミン
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8515934D0 (en) * 1985-06-24 1985-07-24 Janssen Pharmaceutica Nv (4-piperidinomethyl and-hetero)purines
DE3781173T2 (de) * 1986-02-03 1992-12-17 Janssen Pharmaceutica Nv N-heterozyklische-4-piperidinamine enthaltende anti-histaminische zusammensetzungen.
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
FR2618435B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
US5210091A (en) * 1991-06-24 1993-05-11 Neurosearch A/S Imidazole compounds and their use
CA2161876A1 (en) * 1993-05-20 1994-12-08 Den-Ichi Momose 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
CA2322164A1 (en) * 1998-03-06 1999-09-10 Ludo Edmond Josephine Kennis Glycine transport inhibitors
CA2376781A1 (en) 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
CZ20014573A3 (cs) 1999-06-28 2002-05-15 Janssen Pharmaceutica N. V. Inhibitory replikace respiračně syncyciálního viru
EA005027B1 (ru) 1999-06-28 2004-10-28 Янссен Фармацевтика Н.В. Ингибиторы репликации респираторно-синцитиального вируса
CN101230034A (zh) 2000-03-06 2008-07-30 阿卡蒂亚药品公司 用于治疗5-羟色胺相关性疾病的氮杂环化合物
SK10792003A3 (sk) 2001-02-02 2004-07-07 Teva Pharmaceutical Industries Ltd. Spôsob výroby substituovaných 2-(2-pyridylmetyl) sulfinyl -1H-benzimidazolov
NZ571695A (en) 2001-12-28 2010-02-26 Acadia Pharm Inc Spiroazacyclic compounds as monoamine receptor for modulating 5-HT2A receptor-mediated events
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US7253186B2 (en) 2002-06-24 2007-08-07 Carl-Magnus Andersson N-substituted piperidine derivatives as serotonin receptor agents
CA2490397A1 (en) 2002-06-24 2003-12-31 Acadia Pharmaceuticals Inc. N-substituted piperidine derivatives as serotonin receptor agents
US7538222B2 (en) 2002-06-24 2009-05-26 Acadia Pharmaceuticals, Inc. N-substituted piperidine derivatives as serotonin receptor agents
US7601740B2 (en) 2003-01-16 2009-10-13 Acadia Pharmaceuticals, Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
DK1723136T3 (da) * 2003-12-18 2011-06-27 Tibotec Pharm Ltd Piperidinamino-benzimidazol-derivat som inhibitorer af replikation af respiratorisk syncytial virus
ATE435222T1 (de) 2003-12-18 2009-07-15 Tibotec Pharm Ltd Aminobenzimidazole und benzimidazole als inhibitoren der replikation von respiratory syncytial virus
AR046770A1 (es) 2003-12-18 2005-12-21 Tibotec Pharm Ltd Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorio
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
BRPI0516063A (pt) 2004-09-27 2008-08-19 Acadia Pharm Inc sìntese de n-(4-fluorbenzil)-n-(1-metilpiperidin-4-il)-n'-(4-(2-metilp ropi-loxi)fenilmetil)carbamida e seu sal tartarato e formas cristalinas
US7790899B2 (en) 2004-09-27 2010-09-07 Acadia Pharmaceuticals, Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
EP2134330B1 (de) 2007-03-19 2013-05-08 Acadia Pharmaceuticals Inc. Kombinationen aus 5-ht2a-inversagonisten und -antagonisten mit antipsychotika
SI3325444T1 (sl) 2015-07-20 2021-11-30 Acadia Pharmaceuticals Inc. Postopki za pripravo N-(4-fluorobenzil)-N-(1-metilpiperidin-4-il)-N'- (4-(2-metilpropiloksi)fenilmetil)karbamida in njegove tartratne soli in polimorfne oblike C
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
US11464768B2 (en) 2016-12-20 2022-10-11 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis
US11135211B2 (en) 2017-04-28 2021-10-05 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
EP3675827A1 (de) 2017-08-30 2020-07-08 Acadia Pharmaceuticals Inc. Formulierungen von pimavanserin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2857391A (en) * 1955-04-15 1958-10-21 Merck & Co Inc Aminomethylbenzimidazoles
US2971005A (en) * 1958-10-17 1961-02-07 Merck & Co Inc Nu-substituted derivatives of 2-benzylaminobenzimidazoles
BE788065A (fr) * 1971-08-26 1973-02-26 Degussa Nouvelles aza-benzimidazoles et procede pour leur preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Бкшер К., Пирсон Д. Органические синтезы. Ч. 1, М., Мир, 1973, с. 505. . *

Also Published As

Publication number Publication date
NO791097L (no) 1979-10-04
MY8500046A (en) 1985-12-31
ATA242579A (de) 1983-07-15
YU42484B (en) 1988-10-31
CS222779A2 (en) 1987-03-12
JPS641477B2 (de) 1989-01-11
NO154058C (no) 1986-07-09
IL56992A (en) 1983-03-31
PL123380B1 (en) 1982-10-30
CS256358B2 (en) 1988-04-15
IE47818B1 (en) 1984-06-27
YU43158B (en) 1989-04-30
EP0005318B1 (de) 1982-01-06
AU523352B2 (en) 1982-07-22
CA1140119A (en) 1983-01-25
ZA791557B (en) 1980-11-26
NZ189978A (en) 1984-05-31
RO79320A (ro) 1982-08-17
EG13913A (en) 1982-09-30
NO154090B (no) 1986-04-07
NO154058B (no) 1986-04-01
SG29883G (en) 1984-04-19
AU4529679A (en) 1979-10-18
FI64801C (fi) 1984-01-10
JPH01117880A (ja) 1989-05-10
PL214648A1 (de) 1980-03-24
PT69429A (pt) 1979-05-01
IE790676L (en) 1979-10-03
DK169325B1 (da) 1994-10-10
DE2961740D1 (en) 1982-02-25
EP0005318A1 (de) 1979-11-14
YU50283A (en) 1983-12-31
HU182965B (en) 1984-03-28
ES479206A1 (es) 1979-12-16
HK3184A (en) 1984-01-20
JPS54151982A (en) 1979-11-29
AT373887B (de) 1984-02-27
FI64801B (fi) 1983-09-30
YU78479A (en) 1983-10-31
FI791084A7 (fi) 1979-10-04
DK129879A (da) 1979-10-04
JPH0240666B2 (de) 1990-09-12
IL56992A0 (en) 1979-07-25
NO842563L (no) 1979-10-04
NO154090C (no) 1986-07-16
GR64907B (en) 1980-06-07
CY1250A (en) 1984-08-31
PH15877A (en) 1983-04-13
BG38164A3 (bg) 1985-10-15

Similar Documents

Publication Publication Date Title
SU1056902A3 (ru) Способ получени производных @ -гетероциклил-4-пиперидинаминов или их солей
DE69905171T2 (de) Prodrugs für proton-pump-inhibitoren
EP0074341B1 (de) Pharmazeutische Zusammenstellungen
US4045564A (en) Benzimidazole derivatives useful as gastric acid secretion inhibitors
US4965269A (en) Therapeutically active chloro substituted benzimidazoles
US4508905A (en) Substituted 2-(-benzimidazolyl)pyridines
CS196290B2 (en) Process for preparing new compounds
JPS5924157B2 (ja) 新規な化合物の製造法
CA2850644A1 (en) Substituted 4-phenyl-pyridines for the treatment of nk-1 receptor related diseases
NZ208023A (en) Heterocyclic fluoroalkoxy compounds and pharmaceutical compositions
AU2006256778A1 (en) Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenylamino]methyl}-1-methyl-1H-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
PL128510B1 (en) Method of obtaining new piperidine derivatives
CZ279772B6 (cs) Substituované benzimidazoly, způsob jejich výroby a jejich farmaceutické použití
SE457083B (sv) 1-substituerad teobromin, saett att framstaella denna och en farmaceutisk komposition
JP6585718B2 (ja) 抗ヒスタミン剤としての新規ベンゾイミダゾール誘導体
SU1644717A3 (ru) Способ получени производных N-(4-пиперидинил)-бициклического конденсированного 2-имидазоламина, их фармацевтически приемлемых солей присоединени кислот или их стереоизомеров
CZ24396A3 (en) Derivative of dialkoxypyridinylbenzimidazole, process of its preparation and pharmaceutical composition containing thereof
CA2612263C (en) 1-(2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl)-3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
SE447994B (sv) Teobrominderivat och en farmaceutisk komposition med kerlutvidgande, psykotrop eller analgetisk verkan
CS195891A3 (en) Derivatives of thiazolidinecarboxylic acid amides exhibiting anti-allergic activity, their preparation and application
PT91198B (pt) Processo para a preparacao de derivados antiulcera da (alquilditio) quinolina
PL147092B1 (en) Process for preparing novel n-/bicycloheterocyclo/-4-piperidinamines
JP2524420B2 (ja) ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
US5274099A (en) Therapeutically active fluoro substituted benzimidazoles
JP4444908B2 (ja) ２−（２−ピリジルメチルスルフィニル）ベンズイミダゾール系化合物の結晶およびその製造法